The influence of MK-801, glutamate and glycine via the modulation of N-methyl-D-aspartate receptors on isolated rat heart
https://doi.org/10.47093/2218-7332.2020.11.1.15-25
Abstract
N-methyl-D-aspartate (NMDA) receptors belong to the group of inotropic glutamate receptors, which are found in rat cardiomyocytes.
Aim. To evaluate the influence of a non-competitive antagonist of NMDA-receptors — МК-801, separately or in combination with glutamate and/or glycine, on cardiodynamic parameters, coronary flow and oxidative stress biomarkers in isolated rat heart.
Materials and methods. 40 Wistar albino rats were divided into 4 groups (10 rats per group). Aorta of isolated rat heart was cannulated and perfused retrogradely by Krebs-Henseleit buffer in the Langendorf mode. Group 1 received МК-801 (50 µmol/l), group 2 received МК-801 and glycine (100 µmol/l), group 3 received МК-801 and glutamate (100 µmol/l) and group 4 received МК-801, glutamate and glycine. Parameters of cardiac dynamics and coronary blood flow were registered during the last minute of tested substance infusion (E) and at the point when artery perfusate samples were taken at the end of the control period (C). The difference between two points (C and E) was calculated and expressed in percent with a standard deviation.
Results. Group 1 demonstrated the most prominent decrease of peak left ventricle (LV) pressure increase velocity (–47.59 ± 5.65)%, systolic and diastolic LV pressure: (–45.18 ± 4.87)% and (–37.24 ± 5.15)%, respectively and cardiac rate: (–28.63 ± 3.00)%. The most significant decrease of minimal LV pressure increase velocity was observed in group 2: (–47.43 ± 5.68)%, decrease of coronary blood flow — in group 3: (–23.02 ± 2.49)%. The most significant decline of oxidative stress biomarkers — nitrite and hydrogen peroxide — was observed in group 3: (–29.24 ± 2,70)% and (–23.43 ± 3.15)%, respectively; of superoxide anion radical (O2–) — in group 2: (–55.72 ± 6.90)%, of lipid peroxidation index — in group 1: (–35.77 ± 4.49)%.
Conclusion. Administration of МК-801 results in a statistically significant decrease of cardiac dynamic parameters and lipid peroxidation index, compared to MK-801 in combination with glutamate and/or glycine.
About the Authors
N. S. GovorushkinaRussian Federation
Natalia S. Govorushkina, Cardiologist
15, Marshal Timoshenko str., Moscow, 121359
S. B. Bolevich
Russian Federation
Sergey B. Bolevich, MD, PhD, DMSc, Professor, Head of the Human pathology Department
8/2, Trubetskaya str., Moscow, 119991
Tel.: +7 (926) 371-89-93
V. Jakovlevich
Czechoslovakia
Vladimir Jakovljevic, MD, PhD, DMSc, Professor, Dean of the Faculty of Medical Sciences
69, Svetozar Markovic str., Kragujevac, 34000
B. I. Tachieva
Russian Federation
Bella I. Tachieva, assistant professor, Human pathology Department
8/2, Trubetskaya str., Moscow, 119991
S. S. Bolevich
Russian Federation
Stefani S. Bolevich, assistant professor, Pathophysiology Department
8/2, Trubetskaya str., Moscow, 119991
A. S. Orlova
Russian Federation
Aleksandra S. Orlova, MD, PhD, Associate Professor, Human pathology Department
8/2, Trubetskaya str., Moscow, 119991
M. A. Fokina
Russian Federation
Marina A. Fokina, MD, PhD, Associate Professor, Human pathology Department
8/2, Trubetskaya str., Moscow, 119991
A. B. Saltykov
Russian Federation
Alexander B. Saltykov, MD, PhD, DMSc, Professor, Human pathology Department
8/2, Trubetskaya str., Moscow, 119991
E. M. Morozova
Russian Federation
Elena M. Morozova, assistant professor, Human pathology Department
8/2, Trubetskaya str., Moscow, 119991
N. V. Samburova
Russian Federation
Natalia V. Samburova, MD, PhD, Associate Professor, Pathophysiology Department
8/2, Trubetskaya str., Moscow, 119991
M. N. Vukolova
Russian Federation
Marina N. Vukolova, MD, PhD, Associate Professor, Pathophysiology Department
8/2, Trubetskaya str., Moscow, 119991
E. B. Tezikov
Russian Federation
Evgenii B. Tezikov, MD, PhD, DMSc, Professor, Pathophysiology Department
8/2, Trubetskaya str., Moscow, 119991
References
1. Traynelis S.F., Wollmuth L.P., McBain C.J., et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010; 62(3): 405–96. https://doi.org/10.1124/pr.109.002451 PMID: 20716669
2. Martin S.J., Grimwood P.D., Morris R.G. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci. 2000; 23: 649–711. https://doi.org/10.1146/annurev.neuro.23.1.649 PMID: 10845078
3. Wang Z.C., Zhao J., Li S. Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β. Neurosci Bull. 2013; 29(6): 752–60. https://doi.org/10.1007/s12264-013-1383-2 PMID: 24136243
4. Moroni F., Luzzi S., Franchi-Micheli S., Zilletti L. The presence of N-methyl-D-aspartate-type receptors for glutamic acid in the guinea pig myenteric plexus. Neurosci Lett. 1986; 68(1): 57–62. https://doi.org/10.1016/0304-3940(86)90229-6 PMID: 2873540
5. Morhenn V.B., Waleh N.S., Mansbridge J.N., et al. Evidence for an NMDA receptor subunit in human keratinocytes and rat cardiocytes. Eur J Pharmacol. 1994; 268(3): 409–14. https://doi.org/10.1016/0922-4106(94)90066-3 PMID: 7805765
6. Näsström J., Böö E., Ståhlberg M., Berge O.G. Tissue distribution of two NMDA receptor antagonists, [3H]CGS 19755 and [3H]MK-801, after intrathecal injection in mice. Pharmacol Biochem Behav. 1993; 44(1): 9–15. https://doi.org/10.1016/00913057(93)90275-x PMID: 8430132
7. Leung J.C., Travis B.R., Verlander J.W., et al. Expression and developmental regulation of the NMDA receptor subunits in the kidney and cardiovascular system. Am J Physiol Regul Integr Comp Physiol. 2002; 283(4): 964–71. https://doi.org/10.1152/ajpregu.00629.2001 PMID: 12228067
8. Seeber S., Becker K., Rau T., et al. Transient expression of NMDA receptor subunit NR2B in the developing rat heart. J Neurochem. 2000; 75(6): 2472–7. https://doi.org/10.1046/j.14714159.2000.0752472.x PMID: 11080199
9. LeMaistre J.L., Sanders S.A., Stobart M.J., et al. Coactivation of NMDA receptors by glutamate and D-serine induces dilation of isolated middle cerebral arteries. J Cereb Blood Flow Metab. 2012; 32(3): 537–47. https://doi.org/10.1038/jcbfm.2011.161 PMID: 22068228
10. Chen H., Fitzgerald R., Brown A.T., et al. Identification of a h cysteine receptor in the peripheral endothelium and its role in proliferation. J Vasc Surg. Venous Lymphat Disord. 2005; 41(5): 85360. https://doi.org/10.1016/j.jvs.2005.02.021 PMID: 15886671
11. Bozic M., Valdivielso J.M. The potential of targeting NMDA r ceptors outside the CNS. Expert Opin Ther Targets. 2015; 19(3): 399–413. https://doi.org/10.1517/14728222.2014.983900 PMID: 25495517
12. Shi S., Liu T., Li Y., et al. Chronic N-methyl-D-aspartate receptor activation induces cardiac electrical remodeling and increases susceptibility to ventricular arrhythmias. Pacing Clin Electrophysiol. 2014; 37(10): 1367–77. https://doi.org/10.1111/pace.12430 PMID: 24888504
13. Maldonado C., Soni C.V., Todnem N.D., et al. H teinemia and sudden cardiac death: potential arrhythmogenic mechanisms. Curr Vasc Pharmacol. 2010; 8(1): 64–74. https://doi.org/10.2174/157016110790226552 PMID: 19485933
14. Gao X., Xu X., Pang J., et al. NMDA receptor activation i es mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiol Res. 2007; 56(5): 559–69. PMID: 16925458
15. Hachem L.D., Mothe A.J., Tator C.H. Glutamate increases in vitro survival and proliferation and attenuates oxidative stress-induced cell death in adult spinal cord-derived neural stem/progenitor cells via non-NMDA ionotropic glutamate receptors. Stem Cells Dev. 2016; 25(16): 1223–33. https://doi.org/10.1089/scd.2015.0389 PMID: 27316370
16. Jakovljevic V., Milic P., Bradic J., et al. Standardized aronia m nocarpa extract as novel supplement against metabolic syndrome: A rat model. Int J Mol Sci. 2018 Dec 20; 20(1): 149–67. https://doi.org/10.3390/ijms20010006 PMID: 30577476
17. McGee M.A., Abdel-Rahman A.A. Enhanced vascular neuronal nitric-oxide synthase-derived nitric-oxide production underlies the pressor response caused by peripheral N-methyl-D-aspartate receptor activation in conscious rats. J Pharmacol Exp Ther. 2012; 342(2): 461–71. https://doi.org/10.1124/jpet.112.194464 PMID: 22580349